News 15 ago 2022 Versant Ventures establishes Vector BioPharma AG Vector Biopharma is the latest company to be founded by Ridgeline, a discovery engine from Basel-based venture capitalist Versant Ventures. Vecto...
News 06 jul 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
News 30 mar 2021 “A machine that is more intelligent than a human being does not yet exist” Artificial intelligence is expected to create new economic possibilities. But what exactly are they, and how can they be developed? These are the...
News 01 fev 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 09 jan 2024 Molecular Partners and Orano Med announce strategic partnership Molecular Partners and Orano Med are joining forces for the development of protein drugs known as DARPin therapeutics. The radioactive payloads o...
News 10 jan 2024 Noor Biotech opts to establish location in Basel Noor Biotech has established a presence in Basel. The start-up, which is managed by its Saudi Arabian co-founder Nuha Alekhmini, is developing a ...
News 03 mai 2022 New record set for biotech investments The Swiss biotech sector benefitted from investments totaling 3.33 billion Swiss francs overall in 2021. A record level of 2.56 billion Swiss fra...
News 01 dez 2021 Sun Genomics sets up European subsidiary in Fribourg Probiotics specialist Sun Genomics has chosen Fribourg to set up its European subsidiary. This is the first establishment of a US company in West...
Report 21 jul 2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...
News 15 mar 2022 Leman Biotech raises USD 11 million for its immunotherapy boosting protein EPFL spin-off Leman Biotech has raised USD 11 million for its protein that can improve the effectiveness of immunotherapy drugs used to treat som...
News 19 dez 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News 20 dez 2023 Proteomedix and Blue Water Biotech jointly found Onconetix Proteomedix has been acquired by Blue Water Biotech, which is based in Cincinnati in the US State of Ohio. The two firms have now jointly founded...
News 21 jul 2021 GeNeuro raises EUR 6 million for multiple sclerosis treatment GeNeuro, a Geneva-based biopharmaceutical company developing new treatments for neurodegenerative diseases, has raised EUR 6 million through a pr...
News 18 dez 2023 UPM Biomedicals chooses the Basel Area as European bridgehead UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes in nanofibrillar c...
News 11 dez 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain 17 jun 2021 17 jun 2021 Suíça
News 06 dez 2023 Philochem launches clinical trial for tumor imaging Philochem and Blue Earth Diagnostics have examined their first three patients as part of a Phase 1 clinical trial. The trial aims to develop a sm...